SASE:2070

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Saudi Pharmaceutical Industries and Medical Appliances

Market Cap

ر.س7.1b

Last Updated

2021/07/29 16:14 UTC

Data Sources

Company Financials +

Executive Summary

Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. More Details


Snowflake Analysis

Average dividend payer with mediocre balance sheet.

Share Price & News

How has Saudi Pharmaceutical Industries and Medical Appliances's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2070 is more volatile than 75% of SA stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 2070's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of SA stocks.


Market Performance


7 Day Return

2.1%

2070

-3.2%

SA Pharmaceuticals

0.3%

SA Market


1 Year Return

89.8%

2070

-4.8%

SA Pharmaceuticals

14.8%

SA Market

Return vs Industry: 2070 exceeded the SA Pharmaceuticals industry which returned -6.3% over the past year.

Return vs Market: 2070 exceeded the SA Market which returned 14.4% over the past year.


Shareholder returns

2070IndustryMarket
7 Day2.1%-3.2%0.3%
30 Day2.9%-7.8%-1.1%
90 Day33.0%-2.9%0.02%
1 Year93.9%89.8%-3.7%-4.8%19.2%14.8%
3 Year106.0%87.7%29.0%22.6%42.2%29.2%
5 Year95.3%67.6%40.2%29.5%104.7%74.0%

Long-Term Price Volatility Vs. Market

How volatile is Saudi Pharmaceutical Industries and Medical Appliances's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Saudi Pharmaceutical Industries and Medical Appliances undervalued compared to its fair value and its price relative to the market?

65.67x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 2070 (SAR59.5) is trading above our estimate of fair value (SAR7.43)

Significantly Below Fair Value: 2070 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 2070 is poor value based on its PE Ratio (65.7x) compared to the Asian Pharmaceuticals industry average (24.1x).

PE vs Market: 2070 is poor value based on its PE Ratio (65.7x) compared to the SA market (33.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2070's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2070 is overvalued based on its PB Ratio (3.7x) compared to the XA Pharmaceuticals industry average (2.4x).


Future Growth

How is Saudi Pharmaceutical Industries and Medical Appliances forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

14.2%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 2070's forecast earnings growth is above the savings rate (8.8%).

Earnings vs Market: Insufficient data to determine if 2070's earnings are forecast to grow faster than the SA market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 2070's revenue (14.2% per year) is forecast to grow faster than the SA market (3.4% per year).

High Growth Revenue: 2070's revenue (14.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 2070's Return on Equity is forecast to be low in 3 years time (11.8%).


Past Performance

How has Saudi Pharmaceutical Industries and Medical Appliances performed over the past 5 years?

-50.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2070 has high quality earnings.

Growing Profit Margin: 2070 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 2070's earnings have declined by 50.8% per year over the past 5 years.

Accelerating Growth: 2070 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2070 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (21%).


Return on Equity

High ROE: 2070's Return on Equity (4.5%) is considered low.


Financial Health

How is Saudi Pharmaceutical Industries and Medical Appliances's financial position?


Financial Position Analysis

Short Term Liabilities: 2070's short term assets (SAR2.7B) exceed its short term liabilities (SAR1.6B).

Long Term Liabilities: 2070's short term assets (SAR2.7B) exceed its long term liabilities (SAR1.0B).


Debt to Equity History and Analysis

Debt Level: 2070's debt to equity ratio (62.8%) is considered high.

Reducing Debt: 2070's debt to equity ratio has increased from 19.2% to 62.8% over the past 5 years.

Debt Coverage: 2070's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 2070's interest payments on its debt are well covered by EBIT (3.5x coverage).


Balance Sheet


Dividend

What is Saudi Pharmaceutical Industries and Medical Appliances's current dividend yield, its reliability and sustainability?

1.68%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 2070's dividend (1.68%) is higher than the bottom 25% of dividend payers in the SA market (1.46%).

High Dividend: 2070's dividend (1.68%) is low compared to the top 25% of dividend payers in the SA market (4.26%).


Stability and Growth of Payments

Stable Dividend: 2070's dividends per share have been stable in the past 10 years.

Growing Dividend: 2070's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (110.4%), 2070's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 2070's dividends in 3 years are forecast to be covered by earnings (50.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.9yrs

Average management tenure


CEO

Khalid Saleh Al-Khattaf

no data

Tenure

H.E. Khalid Saleh Fahd Al-Khattaf serves as the Chief Executive Officer at Saudi Pharmaceutical Industries and Medical Appliances Corporation. He served as Senior Vice President of Finance and Chief Financ...


Leadership Team

Experienced Management: 2070's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

Experienced Board: 2070's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Saudi Pharmaceutical Industries and Medical Appliances Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Saudi Pharmaceutical Industries and Medical Appliances Corporation
  • Ticker: 2070
  • Exchange: SASE
  • Founded: 1986
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ر.س7.140b
  • Shares outstanding: 120.00m
  • Website: https://www.spimaco.com.sa

Location

  • Saudi Pharmaceutical Industries and Medical Appliances Corporation
  • King Abdul Aziz Road
  • Qassim Industrial City
  • Buraydah
  • Saudi Arabia

Listings


Biography

Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/29 16:14
End of Day Share Price2021/07/29 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.